Fundraising Fox
Andrew Conrad
InvestorGeneral Partner at S32
Find your path to Andrew
Sign up to see every warm intro you have to Andrew
- Paths you didn't know you had: your email and LinkedIn already hold routes to Andrew. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
General Partner at S32 and founder/former CEO and Executive Chairman of Verily, Alphabet's healthcare company. Previously held roles at GV and X, and served as Chief Scientific Officer of LabCorp after co-founding the National Genetics Institute. Holds a PhD in cell biology from UCLA.
Contact· self-published, not guessed
Deals · 2
Alpha SourceBoard seat
via S32 · filed Nov 2022 · $25.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at S32
Frequently asked questions
- Who is Andrew Conrad?
- General Partner at S32 and founder/former CEO and Executive Chairman of Verily, Alphabet's healthcare company. Previously held roles at GV and X, and served as Chief Scientific Officer of LabCorp after co-founding the National Genetics Institute. Holds a PhD in cell biology from UCLA.
- Where does Andrew Conrad work?
- Andrew Conrad is General Partner at S32.
- What boards does Andrew Conrad sit on?
- Andrew Conrad holds tracked board seats at Alpha Source, MedCrypt.
About this profile. Compiled from public sources — S32's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights